Ipilimumab
UMCC 2024.067
Phase 2 mab active
Quick answer
Ipilimumab for Locally Advanced Clear Cell Renal Cell Carcinoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Locally Advanced Clear Cell Renal Cell Carcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active